Cargando…
Clinical trials to assess adjuvant therapeutics for severe malaria
Despite potent anti-malarial treatment, mortality rates associated with severe falciparum malaria remain high. To attempt to improve outcome, several trials have assessed a variety of potential adjunctive therapeutics, however none to date has been shown to be beneficial. This may be due, at least p...
Autores principales: | Varo, Rosauro, Erice, Clara, Johnson, Sydney, Bassat, Quique, Kain, Kevin C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382078/ https://www.ncbi.nlm.nih.gov/pubmed/32709257 http://dx.doi.org/10.1186/s12936-020-03340-3 |
Ejemplares similares
-
Host-Based Prognostic Biomarkers to Improve Risk Stratification and Outcome of Febrile Children in Low- and Middle-Income Countries
por: Balanza, Núria, et al.
Publicado: (2020) -
Malaria, immunity and mental disorders: A plausible relationship?
por: Varo, Rosauro, et al.
Publicado: (2019) -
Opportunities for Improving Outcomes in Severe Malaria: The Role of Blood Glucose Monitoring
por: Torres-Fernandez, David, et al.
Publicado: (2023) -
Adjunctive therapy for severe malaria: a review and critical appraisal
por: Varo, Rosauro, et al.
Publicado: (2018) -
Highlighting the burden of malarial infection and disease in the neonatal period: making sense of different concepts
por: Nhama, Abel, et al.
Publicado: (2020)